Cystic pancreatic lesions: when to watch and when to act?

Abstract

Cystic pancreatic lesions (CPL) represent a growing challenge in gastroenterology, as their detection becomes more prevalent, and their management is increasingly complex. While many CPLs are benign and require only observation, others carry a significant risk of malignant transformation. The key to effective management relies in an accurate risk stratification, which can guide decisions regarding surveillance and treatment. As we move towards more personalized, patient-centered approaches, it is crucial to balance the benefits of early detection and intervention with the risks of overtreatment and the psychological burden on patients. Advances in molecular diagnostics and imaging, combined with improved patient education and shared decision-making, will be essential in shaping the future of CPLs management. The goal is not only to improve patient outcomes but also to ensure that care is compassionate, cost-effective, and aligned with individual patient needs.